Literature DB >> 2767772

The role of Actinobacillus actinomycetemcomitans in periodontal disease.

J de Graaff1, A J van Winkelhoff, R J Goené.   

Abstract

The different forms of periodontitis are all associated with a distinct bacterial flora. However, a clear relationship is described between localized juvenile periodontitis (LJP) and Actinobacillus actinomycetemcomitans. Eleven LJP patients all harboured A. actinomycetemcomitans. The arrest of LJP is often impossible, due to the inability to eliminate A. actinomycetemcomitans. Therefore, antibiotic treatment was introduced in combination with the initial treatment. We studied the effect of periodontal treatment on the microflora and clinical status of periodontal disease patients using different therapies. Group 3 attained the best results (initial treatment and a combination metronidazole and amoxicillin), the group to eliminate A. actinomycetemcomitans effectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767772     DOI: 10.1007/BF01639538

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  24 in total

1.  Haemophili and related bacteria in the human oral cavity.

Authors:  M Kilian; C R Schiott
Journal:  Arch Oral Biol       Date:  1975-12       Impact factor: 2.633

2.  Studies on the aetiology of human actinomycosis. II. Do the other microbes of actinomycosis possess virulence?

Authors:  P HOLM
Journal:  Acta Pathol Microbiol Scand       Date:  1951

3.  Microbiological and clinical effects of surgical treatment of localized juvenile periodontitis.

Authors:  L A Christersson; J Slots; B G Rosling; R J Genco
Journal:  J Clin Periodontol       Date:  1985-07       Impact factor: 8.728

4.  Bacterial invasion of the periodontium in a case of juvenile periodontitis.

Authors:  R Gillett; N W Johnson
Journal:  J Clin Periodontol       Date:  1982-01       Impact factor: 8.728

5.  Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline.

Authors:  J Slots; B G Rosling
Journal:  J Clin Periodontol       Date:  1983-09       Impact factor: 8.728

6.  Selective medium for isolation of Actinobacillus actinomycetemcomitans.

Authors:  J Slots
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

7.  The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults.

Authors:  J Slots; L Bragd; M Wikström; G Dahlén
Journal:  J Clin Periodontol       Date:  1986-07       Impact factor: 8.728

8.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families.

Authors:  J J Zambon; L A Christersson; J Slots
Journal:  J Periodontol       Date:  1983-12       Impact factor: 6.993

10.  Clinical and microbiological evaluation of therapy for juvenile periodontitis.

Authors:  K S Kornman; P B Robertson
Journal:  J Periodontol       Date:  1985-08       Impact factor: 6.993

View more
  3 in total

1.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Efficacy of Natural and Allopathic Antimicrobial Agents Incorporated onto Guided Tissue Regeneration Membrane Against Periodontal Pathogens: An in vitro Study.

Authors:  Neha Mehrotra; Ajay Reddy Palle; Rajani Kumar Gedela; Sanjay Vasudevan
Journal:  J Clin Diagn Res       Date:  2017-01-01

3.  Intraperiodontal pocket: An ideal route for local antimicrobial drug delivery.

Authors:  Sreeja C Nair; K R Anoop
Journal:  J Adv Pharm Technol Res       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.